Picture of Biosynex SA logo

ALBIO Biosynex SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapTurnaround

Brief: Biosynex FY EBITDA Up At 52 Million Euros

March 24 (Reuters) - BIOSYNEX SA  ALBIO.PA :
    * FY TURNOVER AT €153.9M VERSUS €35.2M
    * FY EBITDA MULTIPLIED BY 22.6 TO €52.0M
    * PROPOSITION OF DIVIDEND OF 0,20 EUR PER SHARE
    * GROUP IS CONFIDENT OF MAINTAINING HIGH SALES OF COVID-19
RAPID
TESTS AND HAS SEEN STRONG REVENUE GROWTH SINCE THE BEGINNING OF
2021
    * OVER THE NEXT FEW YEARS, BIOSYNEX EXPECTS EXPORTS TO
BECOME THE
GROUP'S MAIN GROWTH AREA

Source text: https://bit.ly/3ckCAlw
Further company coverage:  ALBIO.PA 
    
    

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00 ;))

Recent news on Biosynex SA

See all news